The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Ratain, Mark J.
Item TypeName
Concept Program Development
Concept Drug Discovery
Academic Article Development of target-based antineoplastic agents.
Academic Article Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
Academic Article Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations.
Academic Article Anticancer drug discovery and development throughout the world.
Academic Article Biomarkers in early cancer drug development: limited utility.
Academic Article Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Academic Article A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.
Academic Article Models of excellence: improving oncology drug development.
Academic Article Opportunities and challenges in the development of experimental drug combinations for cancer.
Academic Article Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.
Academic Article Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
Academic Article The development of a financial toxicity patient-reported outcome in cancer: The COST measure.
Academic Article Harmonization of Renal Function Assessment Is Needed During Early Clinical Development of Oncology Drugs.
Academic Article Development of a pharmacokinetically-guided gemcitabine (dFdC) dosing schedule to reduce potentially excessive plasma dFdC concentrations.
Academic Article The Role of Early-Phase Design-Letter.
Academic Article Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application.
Academic Article Do patent applications and Cooperative Research and Development Agreements between the National Cancer Institute and industry serve the public interest?
Search Criteria
  • Drug discovery
  • development